Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)

APEX Investigators; I. Stukena

doi:10.1161/CIRCULATIONAHA.116.025427

Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)

APEX Investigators, I. Stukena (Member of the Working Group)

Research output: Contribution to journal › Article › peer-review

61 Citations (Scopus)

342 Downloads (Pure)

Original language	English
Pages (from-to)	648-655
Journal	Circulation
Volume	135
Issue number	7
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.116.025427
Publication status	Published - 14 Feb 2017
Externally published	Yes

Keywords*

anticoagulants
cardiology
cardiovascular diseases
intracranial hemorrhages
stroke
thrombosis

Field of Science*

3.2 Clinical medicine

Publication Type*

1.1. Scientific article indexed in Web of Science and/or Scopus database

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1161/CIRCULATIONAHA.116.025427

Extended-Duration BetrixabanFinal published version, 177 KB

Cite this

@article{71a9dcd344ee4684a5686842fa68a723,

title = "Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)",

keywords = "anticoagulants, cardiology, cardiovascular diseases, intracranial hemorrhages, stroke, thrombosis",

author = "{APEX Investigators} and Gibson, {C. Michael} and Gerald Chi and Rim Halaby and Serge Korjian and Yazan Daaboul and Purva Jain and Douglas Arbetter and Goldhaber, {Samuel Z.} and Russel Hull and Hernandez, {Adrian F.} and Alex Gold and Olga Bandman and Harrington, {Robert A.} and Cohen, {Alexander T.} and F. Bello and Ferrari, {A. E.} and H. Jure and S. Macin and M. Oliva and M. Parody and C. Poy and R. Baker and P. Coughlin and S. Finfer and A. Rubinfeld and K. Huber and J. Konig and R. Mathies and H. Schoenerr and I. Adzerikho and V. Koryk and E. Mikhailova and N. Mitkovskaya and S. Pimanov and L. Polonetsy and N. Soroka and D. Blockmans and M. Delforge and A. Dive and F. Lienart and Bizzacchi, {J. Annichino} and E. Fiss and A. Freire and E. Manenti and E. Ramacciotti and S. Raymuno and A. Rocha and B. Dimov and M. Grigorov and I. Stukena",

note = "Members of the APEX Investigators working group are listed in Web of Science database publication.",

year = "2017",

month = feb,

day = "14",

doi = "10.1161/CIRCULATIONAHA.116.025427",

language = "English",

volume = "135",

pages = "648--655",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "7",

}

APEX Investigators & Stukena, I 2017, 'Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)', Circulation, vol. 135, no. 7, pp. 648-655. https://doi.org/10.1161/CIRCULATIONAHA.116.025427

Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban). / APEX Investigators ; Stukena, I. (Member of the Working Group).
In: Circulation, Vol. 135, No. 7, 14.02.2017, p. 648-655.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients

T2 - An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)

AU - APEX Investigators

AU - Gibson, C. Michael

AU - Chi, Gerald

AU - Halaby, Rim

AU - Korjian, Serge

AU - Daaboul, Yazan

AU - Jain, Purva

AU - Arbetter, Douglas

AU - Goldhaber, Samuel Z.

AU - Hull, Russel

AU - Hernandez, Adrian F.

AU - Gold, Alex

AU - Bandman, Olga

AU - Harrington, Robert A.

AU - Cohen, Alexander T.

AU - Bello, F.

AU - Ferrari, A. E.

AU - Jure, H.

AU - Macin, S.

AU - Oliva, M.

AU - Parody, M.

AU - Poy, C.

AU - Baker, R.

AU - Coughlin, P.

AU - Finfer, S.

AU - Rubinfeld, A.

AU - Huber, K.

AU - Konig, J.

AU - Mathies, R.

AU - Schoenerr, H.

AU - Adzerikho, I.

AU - Koryk, V.

AU - Mikhailova, E.

AU - Mitkovskaya, N.

AU - Pimanov, S.

AU - Polonetsy, L.

AU - Soroka, N.

AU - Blockmans, D.

AU - Delforge, M.

AU - Dive, A.

AU - Lienart, F.

AU - Bizzacchi, J. Annichino

AU - Fiss, E.

AU - Freire, A.

AU - Manenti, E.

AU - Ramacciotti, E.

AU - Raymuno, S.

AU - Rocha, A.

AU - Dimov, B.

AU - Grigorov, M.

A2 - Stukena, I.

N1 - Members of the APEX Investigators working group are listed in Web of Science database publication.

PY - 2017/2/14

Y1 - 2017/2/14

KW - anticoagulants

KW - cardiology

KW - cardiovascular diseases

KW - intracranial hemorrhages

KW - stroke

KW - thrombosis

U2 - 10.1161/CIRCULATIONAHA.116.025427

DO - 10.1161/CIRCULATIONAHA.116.025427

M3 - Article

SN - 0009-7322

VL - 135

SP - 648

EP - 655

JO - Circulation

JF - Circulation

IS - 7

ER -